These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27650198)

  • 21. Adaption of the ex vivo mycobacterial growth inhibition assay for use with murine lung cells.
    Painter H; Prabowo SA; Cia F; Stockdale L; Tanner R; Willcocks S; Reljic R; Fletcher HA; Zelmer A
    Sci Rep; 2020 Feb; 10(1):3311. PubMed ID: 32094451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Negative effect of the components of the lysis-centrifugation system in the growth of mycobacteria in MGIT and Septi-Chek AFB liquid media].
    Gamboa F; de la Rosa Z; Bustillo J; Mora MP; Hernández I; Mirque F
    Enferm Infecc Microbiol Clin; 2000 Nov; 18(9):439-44. PubMed ID: 11149167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of cultural conditions on the distribution of Mycobacterium tuberculosis in the spleens and lungs of specific pathogen-free mice.
    Collins FM; Wayne LG; v Montalbine
    Am Rev Respir Dis; 1974 Aug; 110(2):147-56. PubMed ID: 4278310
    [No Abstract]   [Full Text] [Related]  

  • 24. MTBVAC vaccine is safe, immunogenic and confers protective efficacy against Mycobacterium tuberculosis in newborn mice.
    Aguilo N; Uranga S; Marinova D; Monzon M; Badiola J; Martin C
    Tuberculosis (Edinb); 2016 Jan; 96():71-4. PubMed ID: 26786657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of remaining live BCG organisms in vaccinated mice on the maintenance of immunity to tuberculosis.
    Olsen AW; Brandt L; Agger EM; van Pinxteren LA; Andersen P
    Scand J Immunol; 2004 Sep; 60(3):273-7. PubMed ID: 15320884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.
    Xu ZZ; Chen X; Hu T; Meng C; Wang XB; Rao Y; Zhang XM; Yin YL; Pan ZM; Jiao XA
    Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A modified mycobacterial growth inhibition assay for the functional assessment of vaccine-mediated immunity.
    Vergara EJ; Tran AC; Paul MJ; Harrison T; Cooper A; Reljic R
    NPJ Vaccines; 2024 Jul; 9(1):123. PubMed ID: 38956057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of the Mycobacteria Growth Indicator Tube for the bacteriological diagnosis of tuberculosis.
    Diraa O; Fdany K; Boudouma M; Elmdaghri N; Benbachir M
    Int J Tuberc Lung Dis; 2003 Oct; 7(10):1010-2. PubMed ID: 14552573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.
    Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X
    Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the protective efficacy of bacille calmette-Guérin vaccination against aerosol challenge with Mycobacterium tuberculosis and Mycobacterium bovis.
    Williams A; Davies A; Marsh PD; Chambers MA; Hewinson RG
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S299-301. PubMed ID: 10875804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and application of the direct mycobacterial growth inhibition assay: a systematic review.
    Painter H; Harriss E; Fletcher HA; McShane H; Tanner R
    Front Immunol; 2024; 15():1355983. PubMed ID: 38380319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of the effectiveness of the BACTEC MGIT automatic system for culture of mycobacteria in comparison with classical methods of culture. Experience after one year of use].
    Záruba R; Králová M
    Epidemiol Mikrobiol Imunol; 2002 Apr; 51(2):66-70. PubMed ID: 11987582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A practical in vitro growth inhibition assay for the evaluation of TB vaccines.
    Kolibab K; Parra M; Yang AL; Perera LP; Derrick SC; Morris SL
    Vaccine; 2009 Dec; 28(2):317-22. PubMed ID: 19879231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of two mycobacterial strains in performance of the whole blood mycobacterial growth inhibition assay in Indian children.
    Venkataraman A; Shanmugam S; Balaji S; Mani K; Shanmugavel AK; Muthuramalingam K; Hissar S; Thiruvengadam K; Selladurai E; Smuk M; Hanna LE; Prendergast AJ
    Tuberculosis (Edinb); 2022 Dec; 137():102255. PubMed ID: 36252397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The manual MGIT system for the detection of M. tuberculosis in respiratory specimens: an experience in the University Malaya Medical Centre.
    Fadzilah MN; Ng KP; Ngeow YF
    Malays J Pathol; 2009 Dec; 31(2):93-7. PubMed ID: 20514851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An ex vivo culture model for screening drug activity against in vivo phenotypes of Mycobacterium tuberculosis.
    Turner DJ; Hoyle SL; Snewin VA; Gares MP; Brown IN; Young DB
    Microbiology (Reading); 2002 Oct; 148(Pt 10):2929-2936. PubMed ID: 12368426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrocolonies (Granules) Formation as a Cause of False-Negative Results in the MGIT 960 System: Cause Analysis and Correlation with Mycobacterial Species.
    Yu X; Zhao L; Jiang G; Ma Y; Li W; Huang H
    Biomed Res Int; 2015; 2015():501847. PubMed ID: 26618171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical evaluation of the Mycobacteria Growth Indicator Tube (MGIT) compared with radiometric (Bactec) and solid media for isolation of Mycobacterium species.
    Chew WK; Lasaitis RM; Schio FA; Gilbert GL
    J Med Microbiol; 1998 Sep; 47(9):821-7. PubMed ID: 9736164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lactoferrin augments BCG vaccine efficacy to generate T helper response and subsequent protection against challenge with virulent Mycobacterium tuberculosis.
    Hwang SA; Kruzel ML; Actor JK
    Int Immunopharmacol; 2005 Mar; 5(3):591-9. PubMed ID: 15683854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimisation, harmonisation and standardisation of the direct mycobacterial growth inhibition assay using cryopreserved human peripheral blood mononuclear cells.
    Tanner R; Smith SG; van Meijgaarden KE; Giannoni F; Wilkie M; Gabriele L; Palma C; Dockrell HM; Ottenhoff THM; McShane H
    J Immunol Methods; 2019 Jun; 469():1-10. PubMed ID: 30710562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.